• 1
    Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Circulation 1998;98:25742579.
  • 2
    Chun SH, Sager PT, Stevenson WG, et al. Long term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995;76:4750.
  • 3
    Singh BN. Antiarrhythmic actions of amiodarone: A profile of a paradoxical agent. Am J Cardiol 1996;78(Suppl 4A):4153.
  • 4
    Fogoros RN. Class III antiarrhythmic drugs. In: Antiarrhythmic Drugs: A Practical Guide. Maiden , MA : Blackwell Science; 1997: 8289.
  • 5
    Bicer S, Schwartz DS, Nakayama T, Hamlin RL. Hemodynamic and electrocardiographic effects of graded doses of amiodarone in healthy dogs anesthetized with morphine/alpha chloralose. J Vet Intern Med 2000; 14:9095.
  • 6
    Ware WA, Muir WW, Swanson C. Effects of amiodarone on myocardial performance in normal canine hearts and canine hearts with infarcts. Am J Vet Res 1991;52:891897.
  • 7
    Path GJ, Dai XZ, Schwartz JS, et al. Effects of amiodarone with and without polysorbate 80 on myocardial oxygen consumption and coronary blood flow during treadmill exercise in the dogs. J Cardiov-asc Pharmacol 1991;18:1116.
  • 8
    Gagnol JP, Devos C, Clinet M, Nokin P. Amiodarone biochemical aspects and haemodynamic effects. Drugs 1985; 29 (Suppl 3): 110.
  • 9
    Fridericia LS. Die systolendauer im elektrokardiogramm bei nor-malen menchen und bei herzkranken. Acta Med Scand 1920;53:469486.
  • 10
    Boon JA. M-mode echocardiography. In: Manual of Veterinary Echocardiography. Baltimore , MD : Williams & Wilkins; 1998: 103.
  • 11
    Neter J, Kutner MH, Nachtsheim CJ, Wasserman W Single-factor experiments with repeated measures on all treatments. In: Applied Linear Statistical Models, 4th ed. Chicago , IL : Irwin; 1996: 11661176.
  • 12
    Abdollah H, Brennan FJ, Jimmo S, Brien JF. Relationship between myocardial amiodarone concentration and antiarrhythmic effect in dogs with myocardial infarction and electrically induced ventricular arrhythmias. Can J Physiol Pharmacol 1991;69:812817.
  • 13
    Abdollah H, Brien JF, Brennan FJ. Antiarrhythmic effect of chronic oral amiodarone treatment in dogs with myocardial infarction and reproducibly inducible sustained ventricular arrhythmias. J Cardiovasc Pharmacol 1990;15:799807.
  • 14
    Rosenbaum MB, Chiale PA, Halpern MS, et al. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol 1976;38:934944.
  • 15
    Haffajee CI, Love JC, Canada AT, et al. Clinical pharmacoki-netics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 1983;67:13471355.
  • 16
    Rotmensch HH, Belhassen B, Swanson BN, et al. Steady-state serum amiodarone concentrations: Relationships with antiarrhythmic efficacy and toxicity. Ann Intern Med 1984;101:462469.
  • 17
    Kittleson MD, Kienle RD. Drugs used in treatment of cardiac arrhythmias. In: Small Animal Cardiovascular Medicine. St Louis , MO : Mosby; 1998: 513.
  • 18
    Latini R, Connolly SJ, Kates RE. Myocardial disposition of amiodarone in the dogs. J Pharmacol Exp Ther 1983;224:603608.
  • 19
    Naito M, Michelson EL, Kmetzo JJ, et al. Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation. Circulation 1981;63:7079.
  • 20
    Chew CYC, Collet JT, Campbell C, et al. Beneficial effects of amiodarone pretreatment on early ischemic ventricular arrhythmias relative to infarct size and regional myocardial blood flow in the conscious dog. J Cardiovasc Pharmacol 1982;4:10281036.
  • 21
    Calvert AC, Meurs KM. Cardiopulmonary diseases: Doberman pinscher occult cardiomyopathy: Ventricular tachyarrhythmia. In: KirkRW, ed. Current Veterinary Therapy. Philadelphia , PA : WB Saunders; 2000: 756760.
  • 22
    Harris L, McKenna WJ, Rowland E, Krikler DM. Side effects and possible contraindications of amiodarone use. Am Heart J 1983; 106:916923.
  • 23
    Jacobs G, Calvert C, Kraus M. Hepatopathy in 4 dogs treated with amiodarone. J Vet Intern Med 2000;14:9699.
  • 24
    Kerr CR, Rosenbaum MB, Chiale PA. Antiarrhythmic drugs: Amiodarone. In: MesserliFH, ed. Cardiovascular Drug Therapy, 2nd ed. Philadelphia , PA : WB Saunders; 1996: 12471264.
  • 25
    Fogoros RN, Anderson KP, Winkle RA, et al. Amiodarone: Clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation 1983;68:8894.
  • 26
    Ahnve S. Correction of the QT interval for heart rate: Review of different formulas and the use of Bazett's formula in myocardial infarction. Am Heart J 1985;109:568574.
  • 27
    Funck-Brentano C, Jaillon P. Rate corrected QT interval: Techniques and limitations. Am J Cardiol 1993;72:17B22B.
  • 28
    Detweiler DK. The use of electrocardiography in toxicological studies with beagle dogs. In: T.Balazs, ed. Cardiac Toxicology. Boca Raton , FL : CRC Press; 1981: 3382.
  • 29
    Detweiler DK. Electrocardiography in toxicology studies. In: BishopSP, KernsWD, eds. Cardiovascular Toxicology, 1st ed. New York , NY : Pergamon Press; 1997: 95115. Sipes IG, McQueen CA, Gandolfi AJ, eds. Comprehensive Toxicology; vol 6.
  • 30
    Oreto G, Lapresa V, Melluso C, et al. Acute amiodarone poisoning. Description of a case. Arch Mai Coeur Vaiss 1980;73:857861.
  • 31
    Demoulin JC, Bertholet M, Chevigne M, et al. Prognostic significance of electrocardiographic findings in angina at rest. Br Heart J 1981;46:320324.
  • 32
    Sato R, Koumi S, Singer DH, et al. Amiodarone blocks the inward rectifier potassium channel in isolated guinea pig ventricular cells. J Pharmacol Exp Ther 1994;269:12131219.
  • 33
    Middlekauff HR, Stevenson WG, Saxon LA, Stevenson LW. Amiodarone and torsades de pointes in patients with advanced heart failure. Am J Cardiol 1995;76:499502.
  • 34
    Cohen-Armon M, Schreiber G, Sokolovsky M. Interaction of the antiarrhythmic drug amiodarone with the muscarinic receptor in rat heart and brain. J Cardiovasc Pharmacol 1984;6:11481155.
  • 35
    Dekker JM, Crow RS, Folsom AR, et al. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes. Circulation 2000; 102:12391244.
  • 36
    Massie BM, Fisher SG, Radford M, et al. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators. Circulation 1996;93:21282134.
  • 37
    Baghci N, Brown TR, Schneider DS, Banerjee SK. Effect of amiodarone on rat heart myosin isoenzymes. Circ Res 1987;60:621625.
  • 38
    Hudig F, Bakker O, Wiersinga WM. Amiodarone decreases gene expression of low-density lipoprotein receptor at both the mRNA and the protein level. Metabolism 1998;47:10521057.
  • 39
    Padmavathy B, Devaraj SN, Devaraj H. Effects of amiodarone, an antiarrhythmic drug, on serum and liver lipids and serum marker enzymes in rats. Indian J Biochem Biophys 1992;29:522524.